Nitazenes: The Deadly Synthetic Opioids You Might Not Know You're Taking
Article by EZ Test Kits
There's something particularly unsettling about a drug that can be present without the person taking it necessarily knowing that it's there.
That's part of what makes nitazenes different from most of the drugs people are familiar with. You don't necessarily have to go looking for a nitazene to encounter one. These synthetic opioids have increasingly been detected n illicit drugs, including substances sold as other drugs or drugs made to look like legitimate medicines. That's alarming.
So what exactly are nitazenes?
And why has a relatively obscure group of laboratory-made compounds become such a serious concern?
What Are Nitazenes?
Nitazenes are a family of synthetic opioids. Put simply, they are chemicals produced in laboratories that interact with the body's opioid receptors.
They're not one single drug, either. The name refers to a group of related compounds, including substances such as protonitazene, metonitazene, and isotonitazene.
Their story actually begins several decades ago.
Nitazene compounds were developed during research into opioid analgesics in the 1950s and 1960s. They were investigated for their potential as painkillers, but they were never brought to market as medicines. More recently, different members of the family have appeared in illicit drug markets.
A 2025 scientific review reported that 22 different nitazene analogues had been identified in Europe by the end of 2024, illustrating just how quickly this family of compounds has diversified.
And there's an important point here: nitazenes are synthetics drugs. They are made through chemical processes in labs rather than being naturally derived substances.
That doesn't automatically make a drug more dangerous. What matters with nitazenes is the combination of potency, unpredictability, and the possibility of encountering them without knowing it.
In Scotland, wider drug-death figures underline just how serious the presence of nitazenes has become. National Records of Scotland (NRS) recorded 1,133 drug-related deaths in 2025, an increase of 116 deaths compared with 2024.
More than one drug was implicated in 78% of drug-use deaths, highlighting how often modern drug deaths involve combinations of substances rather than a single drug in isolation.
Nitazenes are part of that increasingly complicated picture: they were implicated in 76 drug misuse deaths in Scotland in 2024, more than three times the number recorded in 2023. Scotland continues to have a drug-death rate substantially higher than elsewhere in the UK and Europe, making the country's experience a particularly stark illustration of the risks posed by an increasingly unpredictable illicit drug supply.
The Problem With Potency
Nitazenes vary considerably from one compound to another, so there's no single number that describes how powerful the entire family is.
Some, however, are extremely potent opioids.
Research has found that several nitazene compounds can produce very strong effects at relatively small quantities, with some showing greater potency than fentanyl in laboratory studies. Human data is more limited, and researchers caution against assuming that lab potency measurements translate directly into a particular dose or effect in people.
That uncertainty matters.
With an illicit substance, the person taking it may not know which compound is present, how much there is, or whether it's been mixed evenly throughout the substance.
The result can be an extraordinarily difficult situation to judge.
You Might Not Know You're Taking One
This might be the most important thing to understand about nitazenes.
A person doesn't necessarily decide to take a nitazene. Nitazenes have been found in illicit drug supplies where people believed they were buying something else. Scientific research has documented their presence in substances sold in heroin and in falsified pharmaceutical-style tablets. Indeed, some of these stories have ended in tragic circumstances, as has been covered by mainstream news outlets.
That changes the nature of the risk.
Someone buying an illicit opioid may understand that they are taking a substance with overdose risks. But they may have no idea that a much more potent synthetic opioid has been added,
Counterfeit tablets create another layer of uncertainty. A pill can look convincing without containing what its appearance suggests. There is no reliable way to identify the contents of an illicit drug simply by looking at it.
That's where the story of nitazenes becomes less about a particular drug and more about the changing nature of the illicit drug supply.
A Rapidly Changing Drug Landscape
The appearance of nitazenes isn't an isolated event.
Drug markets have always changed, but synthetics drugs can be produced by modifying chemical structure and introducing new compounds. That means new substances can emerge without the public necessarily having any familiarity with them.
Nitazenes are a good example.
The first nitazene identified on the recreational drug market was isotonitazene in 2019. Since then, an expanding range of related compounds has been identified internationally.
In the UK, the National Crime Agency says nitazenes first appeared at scale in 2023. Since then, they've been connected to around 1,400 deaths in the UK.
Those numbers put the issue into perspective. But nitazenes are part of a much wider problem: the contents of illicit drugs are becoming increasingly difficult to detect.
What Makes A Nitazene Overdose So Dangerous?
Nitazenes are opioids, so the fundamental danger of overdose is the same as with other powerful opioids: respiratory depression.
As opioid activity increases, breathing can become slower and shallower. In a severe overdose, breathing can stop.
The problem becomes particularly acute when the user doesn't know that a potent opioid is present.
The risk can also increase when opioids are combined with other substances that depress the central nervous system, including alcohol or sedative drugs. The NCA specifically warns that polydrug use can increase overdose risk.
There's another complication: nitanezes are not all the same. Their potency and pharmacological properties vary, and researchers are still building a clearer understanding of how individual compounds behave in humans.
In other words, there isn't a simple rule that can tell somebody exactly what to expect.
So Where Does Drug Testing Fit In?
This is where testing can become an important harm-reduction tool.
If the contents of an illicit drug are uncertain, testing can provide information that would otherwise be unavailable.
Nitazene test strips are designed to detect certain compounds n a sample. Independent lab research has found that they can detect a broad range of nitazene analogues, demonstrating their potential as a drug-checking tool.
But this comes with an important qualification: a test is not a guarantee of safety.
Research published in 2025 by scientists at the University of Dundee tested a commonly distributed nitazene immunoassay strip against 36 nitazene compounds. The strips detected 28 of them, or 78%, while eight compounds produced false-negative results under the conditions tested. False positives were also observed in some seized heroid samples containing high concentrations of caffeine.
That finding is important for anyone using drug-testing technology. A negative result should not be interpreted as proof that a substance is safe or free from nitazenes.
Testing is another layer of information - not a magic safety certificate.
Why Testing Still Matters
That limitation doesn't make testing pointless. Quite the opposite.
It tells us exactly how testing should be understood.
When the alternative is having absolutely no information about whether a substance contains a dangerous synthetic opioid, a test can provide an additional piece of evidence. The key is knowing what that evidence means - and what it doesn't mean.
- A responsible approach to testing means understanding:
- what the test is designed to detect
- which substances it may not detect
- that results can be affected by the sample and testing conditions
- that a negative result doesn't guarantee safety
This is especially important with nitazenes because the compounds themselves are changing and the illicit supply is unpredictable.
Know The Signs. Know The Risks
Nitazenes are not a new category of drug. They're synthetic opioids with a history stretching back to laboratory research in the middle of the twentieth century.
What has changed is where they're appearing - and the circumstances in which people can encounter them. A person may knowingly take an opioid. They may not knowingly take a nitazene.
That distinction matters. The most useful response to an increasingly unpredictable drug supply isn't panic. It's information.
And remember that an opioid overdose is a medical emergency. Naloxone can reverse opioid overdose, and it is increasingly being made available through services to people who use opioids and people who may be in a position to witness an overdose.
The modern drug supply doesn't always tell you what you're dealing with. Testing can't remove that uncertainty completely. But knowing more is much better than guessing.